flucoric 200 mg kapszula
ranbaxy uk ltd. - flukonazol -
flucoric 50 mg kapszula
ranbaxy uk ltd. - flukonazol -
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - daganatellenes szerek - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
flucoric 100 mg kapszula
ranbaxy uk ltd. - flukonazol -
flucoric 150 mg kapszula
ranbaxy uk ltd. - flukonazol -
synercid por oldatos infúzióhoz
monarch pharmaceuticals ireland - quinupristine -
casodex 150 mg filmtabletta
astrazeneca kft. - bicalutamide -
klacid 250 mg filmtabletta
viatris healthcare ltd. - klaritromicin -
klacid 500 mg filmtabletta
viatris healthcare ltd. - klaritromicin -
klacid uno 500 mg retard filmtabletta
viatris healthcare ltd. - klaritromicin -